A Study of IBI362 in Chinese Subjects With Obstructive Sleep Apnea and BMI≥28 kg/m2
Clinical trial NCT06931028 · RECRUITING
Trial details
- NCT number
- NCT06931028
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-12
- Primary completion
- 2027-05-07
- Enrollment
- 260
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.